Biosense Webster, Inc.
Benefits of Catheter Ablation with the NAVISTAR® THERMOCOOL® Catheter Sustained for One Year in the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Published in Drug Law Weekly, June 2nd, 2009
In final, one-year results of a multicenter randomized clinical study, catheter ablation demonstrated significantly better outcomes compared to anti-arrhythmic drug (AAD) therapy for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. Atrial fibrillation, or AFib as it is more commonly referred to, is the most prevalent cardiac arrhythmia (heart rhythm disorder), affecting an estimated 20 million people worldwide. It is also one of the most common causes of stroke.
In a presentation here today during the Late Breaking Clinical Trials session at Heart Rhythm 2009, patients receiving cardiac ablation with the NAVISTAR® THERMOCOOL®...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-06-02)
More Articles from Drug Law Weekly
- American Physical Therapy Association
Physical Therapists Advocate for Access to Rehabilitative Services on Capitol Hill - Antiretrovirals
Studies from University of Nigeria provide new data on antiretrovirals - Biovail Corporation
Biovail Announces Termination of HSR Waiting Period, Closing of Acquisition of U.S. Rights to Wellbutrin XL® - Bureau of Alcohol, Tobacco, Firearms and Explosives
ATF Teams Up With Partners in Operation Money Train - Campaign for Tobacco-Free Kids
Sen. Judd Gregg Votes to Protect America's Kids from Tobacco - Change Illinois
CHANGE Illinois! Tells General Assembly Not to Play Games; Says Campaign Contribution Limits Must Cover Legislative Leaders - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
